Improving access to Parkinson’s disease resources on Amazon’s Alexa

News

Author: Simge Eva DoganPublished: 29 October 2020

Prep: Cook: Serves:

US non-profit Parkinson’s Foundation has announced a new partnership with Amazon’s smart speaker Alexa to help more people access resources related to Parkinson’s disease.

As part of the collaboration, Alexa-enabled devices will answer questions about Parkinson’s disease in English and Spanish, citing sources from the Parkinson’s Foundation. The educational initiative is aimed at people with the condition, their care partners, family and friends and health professionals – and will help them find information on topics including Covid-19 and Parkinson’s, symptoms and early signs of the condition, and more.

John L Lehr, president and CEO of the Parkinson’s Foundation, said: “We are thrilled to work with Amazon to move into this exciting world of smart speakers to help even more people gain access to the information about Parkinson’s disease they need most. Our hope is that this partnership will help us further reach and better support the Parkinson’s disease community throughout every stage of their journey.”

Find out more about Parkinson’s Foundation’s partnership with Amazon’s Alexa.

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

Last Month

Next Month

Go Back

Share this story

Comments

Europe

European Union accused of ignoring Parkinson’s

Campaigners are being asked to contact the EU directly

Ask the expert: How does Parkinson’s disease impact dreams?

Dr Daniele Urso shares insights and advice on sleep disturbance

“Finding information about being a woman with Parkinson’s was challenging”

Kathleen Reardon on diagnosis and being heard by doctors

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Scientists in China have developed a method to help improve stem cell research in mice models of Parkinson’s – which could potentially lead to promising new treatments. The researchers, based at the Chinese Academy of Sciences, identified two cell surface markers of dopamine neurons, which are reduced in Parkinson’s. They injected cells with these markers into the brains of the mice and found that this resulted in “higher therapeutic potency” for improving motor symptoms of the condition. As part of their research, the team also worked to control the variability of donor cells, to help improve therapeutic outcomes for Parkinson’s cell therapy. The researchers, whose study was published in ‘The Journal of Clinical Investigation’, described the findings as a “revolutionary step on the road towards more effective and safer stem cell therapies”.

Could frequent nightmares be an early sign of Parkinson’s disease?

A new study has suggested that experiencing recurrent nightmares and bad dreams could be an early symptom of Parkinson’s disease. Researchers from the University of Birmingham, UK, used data from an existing US study that followed 3818 men, aged 67 or older, over a period of 12 years. Participants who reported experiencing bad dreams at least once a week were followed up. During the follow up, 91 people were diagnosed with Parkinson’s. The results suggested that participants who had frequent bad dreams were twice as likely to develop the condition as those who did not. Commenting on the study, lead author Dr Abidemi Otaiku said: “While we need to carry out further research, identifying the significance of bad dreams and nightmares could indicate that individuals who experience changes to their dreams in older age – without any obvious trigger – should seek medical advice.”

More than £2m awarded to research on mitochondria and Parkinson’s disease

Researchers at UK biotech startup NRG Therapeutics are developing potential treatments that may help slow the progression of Parkinson’s by protecting the mitochondria – a part of every human cell that works to power chemical reactions. The company has now received a £2.68m award from government-backed agency Innovate UK to continue its research. Their research built upon previous findings that damage to mitochondria in the substantia nigra – an area of the brain associated with dopamine – may be linked to Parkinson’s. The scientists developed molecules that keep a ‘pore’ in the mitochondria closed, which stops calcium flowing into it, preventing a process that eventually ruptures the powerhouse of the cell and leads to its death. The new funding award follows previous investment from Parkinson’s UK and the Michael J Fox Foundation.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Improving access to Parkinson’s disease resources on Amazon’s Alexa

News

Author: Simge Eva DoganPublished: 29 October 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Europe

European Union accused of ignoring Parkinson’s

Special reports

Ask the expert: How does Parkinson’s disease impact dreams?

Women and Parkinson's

“Finding information about being a woman with Parkinson’s was challenging”

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Could frequent nightmares be an early sign of Parkinson’s disease?

More than £2m awarded to research on mitochondria and Parkinson’s disease

{title}

Subscribe

Improving access to Parkinson’s disease resources on Amazon’s Alexa

News

Author: Simge Eva DoganPublished: 29 October 2020

Last Month

Next Month

Share this story

Comments

Related articles

Europe

European Union accused of ignoring Parkinson’s

Special reports

Ask the expert: How does Parkinson’s disease impact dreams?

Women and Parkinson's

“Finding information about being a woman with Parkinson’s was challenging”

A “revolutionary” step in stem cell therapy for Parkinson’s disease?

Could frequent nightmares be an early sign of Parkinson’s disease?

More than £2m awarded to research on mitochondria and Parkinson’s disease

{title}

Subscribe

Sign in